Defining the optimal revascularization strategy during protected high-risk procedures with Impella

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Devices

Background:

• Complete revascularization (CR) in multi-vessel disease (MVD) is linked to improved patient outcomes.
• Percutaneous left-ventricular assist devices (e.g., Impella heart pump) mitigate hemodynamic compromise in high-risk PCI patients.
• The PROTECT III trial provides insights into Impella-assisted PCI outcomes.

Purpose of the Study:

• To evaluate the impact of Impella-protected percutaneous coronary intervention (PCI) on achieving complete revascularization in complex MVD patients.
• To assess the relationship between CR, lesion preparation strategies, and the need for repeat revascularization.
• To identify key factors essential for achieving CR and improving survival in this patient cohort.

Main Methods:

• Analysis of data from the PROTECT III trial.
• Focus on Impella-protected PCI procedures in patients with complex MVD.
• Evaluation of lesion preparation techniques, intravascular imaging use, and post-interventional treatments.

Main Results:

• Increased CR rates were observed during Impella-protected PCI.
• More extensive lesion preparation and treatment correlated with reduced need for repeat revascularization.
• Procedural guidance, advanced techniques, and optimal medical therapy are vital for CR.

Conclusions:

• Impella support facilitates more comprehensive revascularization in high-risk PCI.
• Extensive lesion preparation and advanced techniques are key to successful CR and improved long-term outcomes.
• Achieving CR through optimized PCI strategies, including device support and medical therapy, is essential for survival.